These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5889838)

  • 1. [Therapeutic indications and results of 8080 CB in gynecology].
    Girard M
    Rev Fr Gynecol Obstet; 1965 Apr; 60(4):281-93. PubMed ID: 5889838
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st results with the ethynodiol diacetate-mestranol combination].
    Mancuso S
    Minerva Ginecol; 1966 Apr; 18(8):433-7. PubMed ID: 5920234
    [No Abstract]   [Full Text] [Related]  

  • 3. Indications for therapy with progestational agents.
    Darragh A
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications and treatment of menstrual disorders with a synthetic progestational hormone, ethynodiol diacetate alone or combined in variable doses with an estrogen].
    Soutoul JH
    Rev Fr Gynecol Obstet; 1969; 64(1):41-55. PubMed ID: 5362109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ovulen in the treatment of the premenstrual syndromes in psychiatric patients].
    Rasmussen R; Hagen A; Ravn J
    Ugeskr Laeger; 1967 Feb; 129(7):224-6. PubMed ID: 5599219
    [No Abstract]   [Full Text] [Related]  

  • 6. Delay of menses test.
    Greenblatt RB
    Pac Med Surg; 1966; 74(3):127-30. PubMed ID: 5935797
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 8. A new method to regulate the female reproductive cycle--therapeutic indications.
    Smith G
    Pac Med Surg; 1965; 73(6):408-12. PubMed ID: 5847210
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral treatment of prolonged dysfunctional bleedings with estrogen-gestagen preparations].
    Rehsteiner HP
    Zentralbl Gynakol; 1969 Feb; 91(6):178-86. PubMed ID: 5405176
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with ethynodiol diacetate combined with mestronal (metrulen).
    McGoogan LS
    Nebr State Med J; 1968 Jul; 53(7):341-3. PubMed ID: 4232054
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors].
    Loskant G; Heinen G
    Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum valproate levels with oral contraceptive use.
    Herzog AG; Farina EL; Blum AS
    Epilepsia; 2005 Jun; 46(6):970-1. PubMed ID: 15946343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of menstruation anomalies and preclimacteric disturbances by Duoluton].
    Tscherne E
    Ther Ggw; 1970 Jan; 109(1):93-4 passim. PubMed ID: 5437260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of a synthetic estro-progestational agent: FH 080].
    Villedieu P
    Presse Med (1893); 1966 Nov; 74(51):2625-6. PubMed ID: 5926994
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sequentaial treatment: estrogen-progestational agents in menstruation disorders].
    Bernard I; Denis JC
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):289-93. PubMed ID: 5711739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with the oral gestagen-estrogen preparation "syngynon oral" in menstruation disorders].
    Mosler W
    Dtsch Gesundheitsw; 1966 Sep; 21(37):1750-2. PubMed ID: 5929211
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of a low dosage estrogen-progestational combination (FH 027-A)].
    Villedieu P
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):329-36. PubMed ID: 5711745
    [No Abstract]   [Full Text] [Related]  

  • 18. [Continuous therapy during menopause].
    Pintiaux C
    Rev Fr Gynecol Obstet; 1969 Apr; 64(4):189-90. PubMed ID: 5363790
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiestrogenic properties of progestagens from the therapeutical aspect of functional bleeding].
    Rudel HW; Kincl FA
    Cesk Gynekol; 1966 Feb; 31(1):82-5. PubMed ID: 5930113
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethynodiol diacetate: clinical experience with a new synthetic oral progestin.
    Puebla RA; Zarate A; Greenblatt RB
    Fertil Steril; 1965; 16(6):805-12. PubMed ID: 5891583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.